All News

Lab work

Repetitive Testing of Anti-dsDNA Antibodies May Predict Flares in SLE

Sheila Reyes, MD

In abstract #0327 presented during the poster session on Saturday, Dr. Ai Li Yeo and colleagues investigated the usefulness of serial anti-dsDNA testing in predicting flares among SLE patients who have persistently positive anti-dsDNA titers. 

Read Article
myositis.jpg

Proposed Cancer Screening for Inflammatory Myositis Patients

Jack Cush, MD

Today's plenary session features a novel proposal on how and which patients with Idiopathic Inflammatory Myopathy (IIM) should be screened for cancer.  Abstract 0002 by Oldroyd et al, entitled "Cancer Screening Recommendations for Patients with Idiopathic Inflammatory Myopathy" took on this thorny practice issue. 

Read Article
RA9003.jpg (keep)

Survival and Mortality in RA: time to move away from “one-size fits all”?

Aurelie Najm, MD, PhD

Patients with RA are known to have a higher mortality risk than the general population.

Read Article
lupus_0.jpg

Exciting Data for SLE: Plenaries from #ACR22

Michael Putman, MD, MSCI

ACR Convergence 2022 promises to be another exciting year for research in systemic lupus erythematosus (SLE), with multiple plenary sessions devoted to therapeutic advancements. Here’s a quick rundown of what to expect!

Read Article
question-mark-1872634_640.jpg

Do biologics help taper steroids in Adult Still’s Disease?

Bella Mehta, MBBS, MS

A Japanese large scale claims data study was able to collect 5-year data to study the treatment patterns in Still’s. In May 2019, intravenous tocilizumab was approved in Japan for Still’s disease. The study was designed to see patterns of steroid exposure before and after the approval of this therapy.

Read Article
pso.arm_.JPG

“Hey PRESTO!” – Early identification of psoriatic arthritis

Patricia Harkins, MD

Despite a wealth of treatment options, a number of notable unmet needs remain in PsA, most notably the significant diagnostic delay that many patients endure. We are all aware that those with psoriatic skin disease are the most at risk cohort for PsA. Identifying patients with psoriasis who have, or are at increased risk of PsA, appears to be the low hanging fruit that we just can’t fully seem to grasp.

Read Article
Saturday: ACR 2022 Daily Recap https://t.co/3WGcxsEtOj

Links:

Dr. John Cush RheumNow ( View Tweet)

Key points in managing MDA5+ DM 1. Monitor lungs - HRCT/PFTs 2. Test muscle endurance (ref: IMACS site) not just strength 3. Close observation 4. MTX/MMF initial treatments 5. Repeat muscle biopsy if diagnosis unclear Meet the Expert Lundberg I, IMM session @RheumNow #ACR22 https://t.co/ZVFsYgDBx2
Dr. Antoni Chan synovialjoints ( View Tweet)
“Rheumatic diseases - diseases of accelerated aging” With age: ⚖️ fat ⬆️ 💪🏻 muscle ⬇️ 👉 results in ⬇️fn ⬇️gait speed ⬇️grip 🌟what can we do? ⚡️start with basic diet and exercise advice ✅caloric restriction (⬇️350cal/day) ✅ resistance training #GeriRheum #ACR22 https://t.co/6KRrwCWBEZ
Patricia Harkins DrTrishHarkins ( View Tweet)
#RheumPearl: Dr. J Stone shares useful #ophthalmology terms that #rheums should know. Note that IOI may not be idiopathic (do the workup- it might be #sarcoid myositis). Does @DGlaucomflecken have anything to add? #ACR22 @rheumnow https://t.co/bxWm7MlePj
TheDaoIndex KDAO2011 ( View Tweet)
Rheumatology Secrets & Pearl Lecture with Dr. John Stone: - Patient presenting with fever, headache, neck pain, and CPPD of multiple joints. - Consider Crowned Dens Syndrome. CT Neck showing calcification around Odontoid Process @RheumNow #ACR22 https://t.co/Md1bqzPyr5
Akhil Sood MD AkhilSoodMD ( View Tweet)
Consensus for #cancer screening in IIM Presented: How Often to Screen #Plenary #ACR22 @rheumnow #myositis https://t.co/h1kp7Z9ynO
TheDaoIndex KDAO2011 ( View Tweet)
Best Overall! by Dr. Lauren Harper #ACR22 Image Competition @rheumnow https://t.co/D3bKJTx6ir
TheDaoIndex KDAO2011 ( View Tweet)
Keynote lecture from Abraham Varghese at #ACR22 @RheumNow Opening Session Physicians and Patients ◦ Physical examination is meaningful and cannot be replaced by technology ◦ Don’t treat the EHR, treat the patient ◦ Acknowledge how much goes into patient care by our nurses https://t.co/piV0O8O7Hw
Dr. Antoni Chan synovialjoints ( View Tweet)
#ACR22 Yr in Review. John Varga says novel vaccination immune therapy may reverse #fibrosis - at least in mice. Hope for #scleroderma & other fibrotic diseases. Data need to be transferred into human experiments @RheumNow https://t.co/ybFRXheQq3
Janet Pope Janetbirdope ( View Tweet)
Ab0344 #ACR22 CKD2+ a/w incr HCQ levels by 149 ng/mL vs CKD1 400 mg/d dose: incr HCQ levels by 448 ng/mL vs 200 Incr body wt by 15 kg -> decr HCQ levels by 82 ng/mL Social determinants didn't effect data >750ng/mL and >1000 predicted of 75% decr flare risk @Rheumnow #ACRBest https://t.co/p21rqnO4ym
Eric Dein ericdeinmd ( View Tweet)
New 2022 EULAR Recommendations for the Management of RA The updated '22 EULAR recommendations for the mgmt of RA were initially presented at EULAR '22, and are now in press delineating the most recent developments and perspectives in RA treatment. https://t.co/xnpOUnpgvy https://t.co/OWcRq7nZ57

Links:

Dr. John Cush RheumNow ( View Tweet)
We want to see how you are taking in #ACR22! Share your favorite pictures from ACR on Twitter and tag #RheumPix and #ACR22 and we'll re-tweet our favorite ones! https://t.co/P41KybUuNw
Dr. John Cush RheumNow ( View Tweet)
Inspiring words from Dr. @cuttingforstone, "For these times, we must heed the call to adventure, find the tools & weapons never thought of before, have courage, have faith, tell our story, find our epiphanies bec this too shall pass..." #ACR22 @RheumNow #RheumTwitter https://t.co/l3DPnIBxq6
sheila RHEUMarampa ( View Tweet)
“The Stone Age did not end because we ran out of stones, it's because we found better technology.” – Dr. A. Verghese on how we need to be smarter about the practice medicine to accomplish more without being bogged down by logistics. #scribes @cuttingforstone @rheumnow #ACR22 https://t.co/20fP8cRRrv
TheDaoIndex KDAO2011 ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×